Director/PDMR Shareholding

About this update from Transense Technologies Plc

12 January 2024 Transense Technologies plc ("Transense" or the "Company")   Director/PDMR shareholding - acquisition of shares   Transense Technologies plc, the provider of specialist sensing solutions and measurement systems, has been notified that Ryan Maughan, Business Development Director, on 11 January 2024, purchased 1,800 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 98 pence per share.   Accordingly, Ryan Maughan's total beneficial shareholding in the Company has increased to 31,807 Ordinary Shares, which represents approximately 0.21% of the Company's current voting rights. Further details are provided in the forms below in accordance with the requirements of the UK Market Abuse Regulation.    For further information please visit www.transense.com or contact: Transense Technologies plc Nigel Rogers (Executive Chairman) Melvyn Segal (CFO) Via Walbrook PR Allenby Capital (Nominated Adviser and Broker) Jeremy Porter / George Payne (Corporate Finance) Stefano Aquilino / Tony Quirke (Sales & Corporate Broking) Tel: +44 (0)20 3328 5656 Walbrook PR Tom Cooper/Nick Rome / Joseph Walker Tel: +44 (0)20 7933 8780 [email protected]     Notes to Editors:   Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring.  Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, automotive (high performance and off-road) and complex machine control.   The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.   Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.  www.transense.com   For further information please contact [email protected].   Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them   1   Details of the person discharging managerial responsibilities / person closely associated   a)   Name   Ryan Maughan 2   Reason for the notification a)   Position/status     Business Development Director b)   Initial notification /Amendment   Initial 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor   a)   Name    Transense Technologies plc b)   LEI   2138005N52J6KKQ3EY67 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted    a)   Description of the financial instrument, type of instrument Ordinary Shares of 10 pence each Identification code GB00BDHDTH21 b)   Nature of the transaction    Purchase of Ordinary Shares c) Price and volume Price: 98 pence per share   Volume: 1,800 d)   Aggregated information - Aggregated volume As above - Price e)   Date of the transaction   11 January 2024 f)   Place of the transaction   London Stock Exchange, AIM  

View stock analysis, news, and events for Transense Technologies Plc